Search research articles
Contact Us
Filters
Showing results (21-30 of 91) with videos related to
Page
of 10
Sort By:
Oncogene
|
May 29, 2003
Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity
Andrew Tutt, Frances Connor, David Bertwistle, et al.
Breast Cancer Research and Treatment
|
June 15, 2011
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Voralak Vichapat, Hans Garmo, Lars Holmberg, et al.
Journal of Immunology Research
|
November 25, 2016
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Fabian Flores-Borja, Sheeba Irshad, Peter Gordon, et al.
NPJ Breast Cancer
|
July 24, 2025
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer
Matthew Fenton, Miki Yoneyama, Erik Wennerberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 13, 2012
Differences in breast cancer hormone receptor status in ethnic groups: a London population
Ruth H Jack, Elizabeth A Davies, Christine Renshaw, et al.
Science Translational Medicine
|
April 11, 2014
Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway
Pierre Vantourout, Carrie Willcox, Andrea Turner, et al.
BMC Genomics
|
November 16, 2012
Molecular characterisation of cell line models for triple-negative breast cancers
Anita Grigoriadis, Alan Mackay, Elodie Noel, et al.
Breast (Edinburgh, Scotland)
|
April 5, 2015
New approaches for improving outcomes in breast cancer in Europe
Angelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.
BMC Bioinformatics
|
October 21, 2011
DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference
Yan Jiao, Katherine Lawler, Gargi S Patel, et al.
Breast Cancer (Tokyo, Japan)
|
April 3, 2023
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
Hideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 91) with videos related to
Sort By:
Page
of 10
Oncogene
|
May 29, 2003
Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity
Andrew Tutt, Frances Connor, David Bertwistle, et al.
Breast Cancer Research and Treatment
|
June 15, 2011
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Voralak Vichapat, Hans Garmo, Lars Holmberg, et al.
Journal of Immunology Research
|
November 25, 2016
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Fabian Flores-Borja, Sheeba Irshad, Peter Gordon, et al.
NPJ Breast Cancer
|
July 24, 2025
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer
Matthew Fenton, Miki Yoneyama, Erik Wennerberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 13, 2012
Differences in breast cancer hormone receptor status in ethnic groups: a London population
Ruth H Jack, Elizabeth A Davies, Christine Renshaw, et al.
Science Translational Medicine
|
April 11, 2014
Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway
Pierre Vantourout, Carrie Willcox, Andrea Turner, et al.
BMC Genomics
|
November 16, 2012
Molecular characterisation of cell line models for triple-negative breast cancers
Anita Grigoriadis, Alan Mackay, Elodie Noel, et al.
Breast (Edinburgh, Scotland)
|
April 5, 2015
New approaches for improving outcomes in breast cancer in Europe
Angelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.
BMC Bioinformatics
|
October 21, 2011
DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference
Yan Jiao, Katherine Lawler, Gargi S Patel, et al.
Breast Cancer (Tokyo, Japan)
|
April 3, 2023
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
Hideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
Page
of 10